🧪
hypothesis

GFAP-positive reactive astrocyte states as mediators of regional metabolic vulnerability in AD requires proximal validation

Hypothesis

GFAP-positive reactive astrocyte states as mediators of regional metabolic vulnerability in AD requires proximal validation

The debate supports carrying forward GFAP-positive reactive astrocyte states as mediators of regional metabolic vulnerability in AD only if a proximal endpoint changes before the late outcome.
🧬 GFAP🩺 neurodegeneration🎯 Composite 60%💱 $0.55▼7.2%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 1 support✗ 1 oppose
✓ All Quality Gates Passed
Mechanistic 0.67 (15%) Evidence 0.57 (15%) Novelty 0.64 (12%) Feasibility 0.69 (12%) Impact 0.58 (12%) Druggability 0.50 (10%) Safety 0.55 (8%) Competition 0.55 (6%) Data Avail. 0.63 (5%) Reproducible 0.66 (5%) KG Connect 0.12 (8%) 0.604 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite60%

🧪 Overview

The debate supports carrying forward GFAP-positive reactive astrocyte states as mediators of regional metabolic vulnerability in AD only if a proximal endpoint changes before the late outcome. The decisive validation path is: resolve GFAP-positive astrocyte subtypes by spatial transcriptomics and perturb metabolic support pathways in neuron-astrocyte systems.

🧬 Mechanism

No curated mechanism pathway recorded for this hypothesis.

⚖️ Evidence

⚖️ Evidence Matrix1 supports1 contradicts
Supports
Preregistered claim: GFAP-positive reactive astrocytes mediate regional vulnerability through dysfunction of metabolic support, driving AD progression in affected regions
AD-MASTER-PLAN-GFAP-20260428030756
Contradicts
GFAP is a state marker more than a specific intervention point, and reactive astrocytes can be protective or harmful
AD-MASTER-PLAN-GFAP-20260428030756
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — GFAP

🧬 PDB 3B2M Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for GFAP →

No DepMap CRISPR Chronos data found for GFAP.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
↔
Stable
7d Momentum
▼ 0.4%
Volatility
Low
0.0015
Events (7d)
2
Price History
▼7.2%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

View on SciDEX ↗